Disclaimer: CME certification for these activities has expired. All information is pertinent to the timeframe in which it was released.
Conquering the Ravages of Metabolic Syndrome
More than 1 in 5 US adults have the metabolic syndrome, a cluster ofcardiovascular and metabolic abnormalities including obesity, atherogenicdyslipidemia, insulin resistance, and hypertension. The metabolicsyndrome is clinically important because it is a risk factor fortwo major killers: type 2 diabetes and cardiovascular disease.Dyslipidemia, a cardinal component of the metabolic syndrome, is awell-established risk factor for cardiovascular disease.The metabolicsyndrome is characterized by mixed dyslipidemia, including elevatedlow-density lipoprotein cholesterol, elevated triglycerides, and lowhigh-density lipoprotein cholesterol.This Webcast is designed to providepracticing clinicians with comprehensive clinical information to assist in the management of the metabolic syndrome.
At the conclusion of this activity, participants should be able to:
- Discuss causes of the recent increase in the prevelance of metabolic syndrome, stressing the importance of detection, evaluation, and treatment of high blood cholesterol in adults.
- Provide an overview of the pathophysiology of lipids and lipoproteins.
- Indicate effective treatment stategies according to the National Cholesterol Education Program Adult Treatment Panel III guidelines.
- Implement the United States Preventive Services Task Force recommendations in the screening for lipid disorders.
- Explain the benefits of omega-3 fatty acids, focusing on the American Heart Association recommended intake and Food and Drug Administration approval for update food labels.
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.5 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
This activity is designed for cardiologists, endocrinologists, diabetologists, internists, family practitioners, and all other allied healthcare professionals involved in the management and treatment of cardiovascular disease. There are no prerequisites for attendees.
Statement of Responsibility
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Policy on Faculty and Provider Disclosure
It is the policy of the Johns Hopkins School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of the drugs or devices during the presentation(s). Detailed disclosure will be made in the course handout materials.
Americans with Disabilities Act
The Johns Hopkins University School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.
ROGER BLUMENTHAL, MD, FACC, FCCP
Associate Professor of Medicine
Director, Preventive Cardiology
The Johns Hopkins Ciccarone Center
MICHAEL H. DAVIDSON, MD
Director of Preventive Cariology
Rush University Medical Center
PHILIPPE O. SZAPARY, MD, MSCE
Assistant Professor of Medicine
Division of General Internal Medicine and
Cardiovascular Risk Intervention Program
University of Pennsylvania School of Medicine